AAV Capsid Screening Kits

Through a strategic partnership and co-development with Children’s Medical Research Institute (CMRI), our high-throughput, barcoded AAV capsid panels enable rapid, cost-efficient capsid selection using a proven model that delivers both DNA and RNA readouts for simultaneous analysis of AAV entry and expression—dramatically accelerating AAV-based gene therapy development.

Our kit’s unique barcode system accommodates hundreds of capsids in a single panel, available as:

• Pre-selected Tissue Tropism Panels with optimized natural serotypes and engineered variants for superior tissue-specific performance.
• Full Capsid Screening Panels for comprehensive evaluation of all available capsids in a single experiment.
• Customizable Panels from a vast pool of capsids—including exclusive CMRI and PackGene candidates—tailored to your payloads and experimental models.

Each vector is individually produced, pre-quantified, and pooled at equimolar ratios, with barcodes inserted into the 3′ untranslated region of a standardized reporter cassette. This enables multiplexed NGS-based quantification of both physical  (DNA) and functional (RNA) transduction efficiency—reducing time, cost, and variability compared to traditional reporter assays, and quickly revealing the most clinically relevant AAV vectors.